An investigation of the impact of p16INK4A expression in GBM revealed that GBM with higher p16INK4A expression is associated with senescence phenotypes and greater infiltration of immune cells compared to GBM with lower p16INK4A expression. The gene discussed is CDKN2A; the disease is glioblastoma.